PMA device
Pain Rechargeable (RC) Spinal Cord Stimulation (SCS) System: Inceptiv LT Implantable Neurostimulator (Model 977117)
Medtronic Neuromodulation · Stimulator, Spinal-Cord, Totally Implanted For Pain Relief (LGW, Class III) · First FDA decision Apr 24, 2024, newest Apr 24, 2024Chronic pain
Last checked: Nov 20, 2026Source: FDA, CMS, ClinicalTrials.gov, PubMed
FDA decisions
1
PMA pathway
Device trials
21
Naming "Pain Rechargeable"
MAUDE reports
0
Brand "Pain Rechargeable", since 2015
PubMed studies
0
Mentioning "Pain Rechargeable"
AI summary across all sources
Written by AI from the FDA, CMS, ClinicalTrials.gov, MAUDE and PubMed data on this page, plus web searches for payment facts.
Product review deck
A slide deck reviewing Pain Rechargeable (RC) Spinal Cord Stimulation (SCS) System: Inceptiv LT Implantable Neurostimulator (Model 977117)
About ten slides on the technology, clinical evidence, regulatory history and commercialization, built with AI from the data on this page and web research, with sources. Download it as PowerPoint to edit or as PDF to share.
- Executive summary and key facts
- Technology
- Clinical evidence and trials
- Regulatory history and safety
- Reimbursement, market and competition
- Risks, outlook and sources
AI-written from public data and may contain mistakes. Check each fact against its source before relying on it. Not investment, legal, reimbursement or medical advice.
FDA decisions
The newest 1 of 1 decisions filed under this name.
- Pain Rechargeable (RC) Spinal Cord Stimulation (SCS) System: Inceptiv LT Implantable Neurostimulator (Model 977117); IntPMA supplement
P840001-S512 · Decided Apr 24, 2024 · 785 days after receipt · Normal 180 Day Track
Device type: Stimulator, spinal-cord, totally implanted for pain relief (LGW) · Neurology & Neurosurgery
Medicare coverage
National and local coverage documents whose titles match this device or its device type. Payment add-ons (NTAP, pass-through, TCET) and likely codes are covered in the summary above.
No Medicare coverage document has a title matching this device or device type. Many devices are paid under existing codes without one.
Clinical trials
Device studies on ClinicalTrials.gov that name "Pain Rechargeable", any status and sponsor, newest update first.
- A First in Human Feasibility Study to Evaluate the Safety and Effectiveness of the BIOTRONIK Prospera SCS System With HomeStream Remote ManagementActive, not recruiting
Biotronik, Inc.Not on our public-company list
NCT04683718 · 60 participants (planned) · Start Sep 20, 2021 · Primary completion Aug 21, 2025
Device: Permanent implant of a BIOTRONIK Prospera SCS (Spinal Cord Stimulation) System with HomeStream Remote Management · For: Chronic Low-back Pain; Chronic Leg Pain
Sites: Broadmeadow, Australia; Hurstville, Australia; Wahroonga, Australia · 5 sites in all
- PDN Post Market, Multicenter, Prospective, Global Clinical StudyActive, not recruiting
Nevro CorpNot on our public-company list
NCT05301816 · 497 participants (planned) · Start Jul 5, 2022 · Primary completion Oct 2027
Device: Spinal Cord Stimulator (SCS) · For: Diabetic Neuropathy, Painful
Sites: Anchorage, Alaska; Ann Arbor, Michigan; West Bloomfield, Michigan · 8 sites in all
- Spinal Cord Stimulation Combined With Physical Therapy in Post-Stroke Upper-Limb Motor HemiparesisRecruiting
Marco CapogrossoAcademic, hospital or other
NCT07153536 · 20 participants (planned) · Start Jan 6, 2026 · Primary completion Aug 31, 2027
Device: Spinal Cord Stimulator (Medtronic Inceptiv™ System) · For: Stroke; Spinal Cord Injuries and Disorders; Hemiparesis After Stroke
Sites: Pittsburgh, Pennsylvania
18 more trials with a free account
Adverse event reports (MAUDE)
Reports received since 2015 naming the brand "Pain Rechargeable", and for the whole product code for context.
This brand
0 reports: 0 malfunction, 0 injury, 0 death
Whole product code LGW
301,867 reports: 79,174 malfunction, 220,939 injury, 1,642 death
Newest reports for this brand
No MAUDE reports name this brand.
Recalls
From FDA's recall database. FDA lists each recalled product separately, so one recall can appear several times. A recall is often a correction or a labeling change, not a removal from the market.
Z-0372-2025 · Started Sep 18, 2024 · Posted by FDA Nov 13, 2024
Reason given: The Wireless Rechargers in the kits may be unable to enter a recharging session upon first use.
Cause as FDA categorized it: Under Investigation by firm · Device type: Stimulator, Spinal-Cord, Totally Implanted For Pain Relief (LGW)
Z-1691-2024 · Started Mar 28, 2024 · Posted by FDA Apr 26, 2024
Reason given: inability to reprogram one device
Cause as FDA categorized it: Under Investigation by firm · Device type: Stimulator, Spinal-Cord, Totally Implanted For Pain Relief (LGW)
Z-0780-2024 · Started Dec 19, 2023 · Posted by FDA Jan 22, 2024
Reason given: Medtronic has discovered an instance in which the Intellis A710 Clinician Programmer Application (CP App) could no longer establish a session with the Implantable Neurostimulator (INS) which resulted in the inability for the clinician to adjust stimulation parameters. In the event of this issue, the patient may...
Cause as FDA categorized it: Under Investigation by firm · Device type: Stimulator, Spinal-Cord, Totally Implanted For Pain Relief (LGW)
6 more recall records with a free account
Published research
The most relevant PubMed records for "Pain Rechargeable"[tiab]. The summary above synthesizes these.
No PubMed record mentions this device by name.
Other devices of this type
Also filed under product code LGW.
- Precision Spinal Cord Stimulator (SCS) SystemsBoston Scientific Corp · PMA 2026
- Senza Spinal Cord Stimulation (SCS) SystemNevro Corporation · PMA 2025
- Saluda Medical Evoke SCS SystemSaluda Medical Pty, Ltd. · PMA 2026
- Master RestoreMedtronic Neuromodulation · PMA 2026
- RestoreMedtronic Neuromodulation · PMA 2025
- Genesis and Eon Family Neurostimulation (Ipg) SystemsAbbott Medical · PMA 2016
- Genesis Neurostimulation SystemAbbott Medical · PMA 2024
- Precision Spectra Spinal Cord Stimulator (SCS) SystemBoston Scientific Corp · PMA 2021
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.